Transactions
Aug. 7, 2001
Cooley Godward: MOLECULAR DEVICES OBTAINS SWISS DRUG-SCREENING FIRM
Sunnyvale's Molecular Devices Corp. will buy Lausanne, Switzerland's Cytion SA for $7.5 million in cash and 400,000 shares of Molecular Devices common stock.
Sunnyvale's Molecular Devices Corp. will buy Lausanne, Switzerland's Cytion SA for $7.5 million in cash and 400,000 shares of Molecular Devices common stock.
Molecular Devices makes bioanalysis systems that automate drug-discovery tasks.
Cytion develops drug-screening technology for the functional analysis of ion-ch...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In